These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24583770)

  • 1. Phosphodiesterases maintain signaling fidelity via compartmentalization of cyclic nucleotides.
    Lomas O; Zaccolo M
    Physiology (Bethesda); 2014 Mar; 29(2):141-9. PubMed ID: 24583770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.
    Brescia M; Zaccolo M
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.
    Fischmeister R; Castro LR; Abi-Gerges A; Rochais F; Jurevicius J; Leroy J; Vandecasteele G
    Circ Res; 2006 Oct; 99(8):816-28. PubMed ID: 17038651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotides: the current dilemma!
    Trewavas AJ; Rodrigues C; Rato C; Malhó R
    Curr Opin Plant Biol; 2002 Oct; 5(5):425-9. PubMed ID: 12183181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases.
    Conti M; Mika D; Richter W
    J Gen Physiol; 2014 Jan; 143(1):29-38. PubMed ID: 24378905
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.
    Sharma S; Kumar K; Deshmukh R; Sharma PL
    Eur J Pharmacol; 2013 Aug; 714(1-3):486-97. PubMed ID: 23850946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterases link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling.
    de Oliveira SK; Smolenski A
    Biochem Pharmacol; 2009 Feb; 77(4):723-33. PubMed ID: 18805402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.
    Cheepala S; Hulot JS; Morgan JA; Sassi Y; Zhang W; Naren AP; Schuetz JD
    Annu Rev Pharmacol Toxicol; 2013; 53():231-53. PubMed ID: 23072381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.
    Mehats C; Andersen CB; Filopanti M; Jin SL; Conti M
    Trends Endocrinol Metab; 2002; 13(1):29-35. PubMed ID: 11750860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE 2013, Paris, France: another exciting workshop for cyclic AMP, protein kinase A, and phosphodiesterases.
    Stratakis CA; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):825-6. PubMed ID: 25398031
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.
    Conti M; Beavo J
    Annu Rev Biochem; 2007; 76():481-511. PubMed ID: 17376027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDE 2015: cAMP Signaling, Protein Kinase A (PKA) and Phosphodiesterases (PDEs): How Genetics Changed the Way We Look at One of the Most Studied Signaling Pathways.
    Stratakis CA; Kelestimur F; Bertherat J
    Horm Metab Res; 2017 Apr; 49(4):237-239. PubMed ID: 28427096
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot.
    Argyrousi EK; Heckman PRA; Prickaerts J
    Neurosci Biobehav Rev; 2020 Jun; 113():12-38. PubMed ID: 32044374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cyclic nucleotide phosphodiesterases in Xenopus laevis ovary.
    Allende C; Plaza M
    Comp Biochem Physiol B; 1987; 88(2):581-7. PubMed ID: 2827950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second messengers and divergent HD-GYP phosphodiesterases regulate 3',3'-cGAMP signaling.
    Wright TA; Jiang L; Park JJ; Anderson WA; Chen G; Hallberg ZF; Nan B; Hammond MC
    Mol Microbiol; 2020 Jan; 113(1):222-236. PubMed ID: 31665539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second messenger system in neoplasia.
    Criss WE
    Oncology; 1974; 30(1):43-80. PubMed ID: 4155059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclic nucleotides normally and in pathology].
    Korovkin BF; Kozhemiakin LA; Kozlov AV
    Voen Med Zh; 1978 Dec; (12):35-40. PubMed ID: 216140
    [No Abstract]   [Full Text] [Related]  

  • 20. Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMP.
    Houslay MD
    Adv Enzyme Regul; 1995; 35():303-38. PubMed ID: 7572351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.